Abstract: A memory cell includes a first anti-fuse element, a first select transistor, a second anti-fuse element, a second select transistor, and a sensing control circuit. The first anti-fuse element is coupled to an anti-fuse control line, and the first select transistor transmits a voltage between a first bit line and the first anti-fuse element according to a voltage on the word line. The second anti-fuse element is coupled to the anti-fuse control line. The second select transistor transmits a voltage between a second bit line and the second anti-fuse element according to the voltage on the word line. The sensing control circuit provides a discharging path to a system voltage terminal from the first select transistor or the second select transistor according to states of the first anti-fuse element and the second anti-fuse element during a read operation.

Abstract: A memory cell includes a first anti-fuse element, a second anti-fuse element, and a selection circuit. The first anti-fuse element has a first terminal, a second terminal being floating, and a control terminal coupled to a first anti-fuse control line. The second anti-fuse element has a first terminal coupled to the first terminal of the first anti-fuse element, a second terminal being floating, and a control terminal coupled to a second anti-fuse control line. The selection circuit is coupled to the first terminal of the first anti-fuse element, the first terminal of the second anti-fuse element, and a source line. The selection circuit controls an electrical connection from the source line to the first terminal of the first anti-fuse element and the first terminal of the second anti-fuse element.

Abstract: A method for anonymously communicating data that defines a token from a source system to a destination system via a block-chain distributed database includes receiving, at a token distribution system, request information from a source system. The request information specifies source identifying information and an address for receiving one or more tokens. The token distribution system determines one or more tokens for allocation to the source system and communicates the allocated tokens to the address defined in the request information via a zero-knowledge transaction. The source system moves the tokens to a different address for communicating a block-chain transaction and communicates the tokens at the different address to a destination address associated with the destination system via a block-chain transaction.

Abstract: A master oracle may receive an oracle network identifier for an oracle network. The master oracle may receive a plurality of data messages respectively generated by the oracles. The master oracle may verify, based on respective public keys for the oracles, that each of the data messages are digitally signed by a different corresponding one of the oracles. The master oracle may aggregate the data messages into an aggregated data message. The master oracle may digitally sign the aggregated data message with a private key and public key pair. The master oracle may transmit the aggregated data message to a participant node of a distributed ledger network. A smart contract stored on a blockchain may verify the aggregated data. After receiving and verifying the aggregated data message the smart contract may execute to perform operations based on the aggregated data message.

Abstract: A memory circuit includes a memory cell, a first program driver, a second program driver, and a sensing amplifier. A method for operating the memory circuit includes, during a program operation of the memory cell, providing a program voltage to the memory cell, enabling the first program driver to drive the first local bit line to be at a low voltage, enabling the second program driver, disabling the first program driver, and enabling the sensing amplifier to verify whether the first memory cell has been programmed or not. The second program driver has a weaker driving ability than the first program driver.

Abstract: A sensing amplification circuit includes a sensing amplifier and a trigger control circuit. The sensing amplifier receives a data voltage and a reference voltage, and outputs a first data signal and a second data signal by comparing the data voltage and the reference voltage. The trigger control circuit includes a logic circuit and a set-reset latch. The logic circuit receives the first data signal and the second data signal, and changes a first control signal from a first voltage level to a second voltage level when one of the first data signal and the second data signal changes its state. The first set-reset latch receives the first control signal and a second control signal, and generates a trigger signal to enable the sensing amplifier when the second control signal changes state and disable the sensing amplifier when the first control signal changes state.

Abstract: This invention provides a new high flux reverse osmosis (RO) membrane comprising a nanoporous polyethersulfone (PES)/polyethylene oxide-polysilsesquioxane (PEO-Si) blend support membrane (PES/PEO-Si) comprising a polyethylene oxide-polysilsesquioxane (PEO-Si) polymer and a polyethersulfone (PES) polymer, a hydrophilic polymer inside the pores on the skin layer surface of the polyethersulfone/polyethylene oxide-polysilsesquioxane blend support membrane, and a thin, nanometer layer of cross-linked polyamide on the skin layer surface of said polyethersulfone/polyethylene oxide-polysilsesquioxane blend support membrane, and a method of making such a membrane. This invention also provides a method of using the new high flux reverse osmosis membrane comprising nanoporous PES/PEO-Si blend support membrane for water purification.

Abstract: This invention provides a new high selectivity stable facilitated transport membrane comprising a polyethersulfone (PES)/polyethylene oxide-polysilsesquioxane (PEO-Si) blend support membrane, a hydrophilic polymer inside the pores on the skin layer surface of the PES/PEO-Si blend support membrane; a hydrophilic polymer coated on the skin layer surface of the PES/PEO-Si blend support membrane, and metal salts incorporated in the hydrophilic polymer coating layer and the skin layer surface pores of the PES/PEO-Si blend support membrane, and methods of making such membranes. This invention also provides a method of using the high selectivity stable facilitated transport membrane comprising PES/PEO-Si blend support membrane for olefin/paraffin separations such as propylene/propane and ethylene/ethane separations.

Abstract: Blockade of immune checkpoints such as cytotoxic T-lymphocyte antigen-4 (CTLA-4) and programmed death-1 (PD-1) shows promise in patients with cancer. Inhibitory antibodies directed at these receptors have been shown to break immune tolerance and promote anti-tumor immunity. These agents work particularly well in patients with a certain category of tumor. Such tumors may be particularly susceptible to treatment because of the multitude of neoantigens which they produce.

Abstract: A method for anonymously communicating data that defines a token from a source system to a destination system via a block-chain distributed database includes receiving, at a token distribution system, request information from a source system. The request information specifies source identifying information and an address for receiving one or more tokens. The token distribution system determines one or more tokens for allocation to the source system and communicates the allocated tokens to the address defined in the request information via a zero-knowledge transaction. The source system moves the tokens to a different address for communicating a block-chain transaction and communicates the tokens at the different address to a destination address associated with the destination system via a block-chain transaction.

Abstract: Blockade of immune checkpoints such as cytotoxic T-lymphocyte antigen-4 (CTLA-4) and programmed death-1 (PD-1) shows promise in patients with cancer. Inhibitory antibodies directed at these receptors have been shown to break immune tolerance and promote anti-tumor immunity. These agents work particularly well in patients with a certain category of tumor. Such tumors may be particularly susceptible to treatment because of the multitude of neoantigens which they produce.

Abstract: Blockade of immune checkpoints such as cytotoxic T-lymphocyte antigen-4 (CTLA-4) and programmed death-1 (PD-1) shows promise in patients with cancer. Inhibitory antibodies directed at these receptors have been shown to break immune tolerance and promote anti-tumor immunity. These agents work particularly well in patients with a certain category of tumor. Such tumors may be particularly susceptible to treatment because of the multitude of neoantigens which they produce.

Abstract: Example embodiments of the present invention comprise an analyte sensing patch, comprising a substrate, and a sensing agent disposed on the substrate such that analyte can encounter the sensing agent through a side of the patch disposed adjacent the skin of a subject but not through a side of the patch disposed away from the skin of the subject. Example embodiments of the present invention comprise an analyte sensing patch, comprising a substrate, a sensing material disposed on the substrate in a first region thereof, an adhesive disposed on the substrate in a second region thereof, wherein the second region surrounds the first region, wherein the sensing agent undergoes a change in a discernible characteristic responsive to encounter with a predetermined analyte.

Abstract: The invention relates to 3,4-diaminopyridine salts, pharmaceutical compositions containing at least one of said salts and uses thereof for the treatment of botulism, myasthenia, myasthenic syndromes or fatigue.

Abstract: The invention relates to 3,4-diaminopyridine salts, pharmaceutical compositions containing at least one of said salts and uses thereof for the treatment of botulism, myasthenia, myasthenic syndromes or fatigue.

Abstract: Method and arrangement for dispersing fuel 62 within a fuel containment system 60 of an aircraft 30 including utilizing a fuel containment system on an aircraft that is located at least partially within a wing 34 of the aircraft and defines a reservoir portion 42 and a remote portion 44. Fuel is pumped during at least aircraft flight operation from the reservoir portion to the remote portion at a pumped rate 80, while simultaneously fuel that is contained in the remote portion of the fuel containment system is permitted to drain to the reservoir portion at a drainage rate 82. The drainage rate is less than the pumped rate. A fuel mass 64 is accumulated in the remote portion of the fuel containment system because of a difference between the pumped rate and the drainage rate and as a result, a counteractive moment 49 is induced in the aircraft that is opposingly directed to a lift moment 46 caused by wing-lift 45 during aircraft flight.

Abstract: A method, apparatus, and article of manufacture for a computer implemented packet processor. The packet processor processes packets in parallel. In particular, the packet processor performs a combination of encryption and authentication on data packets. The encryption and authentication processing of a second data packet may begin before the encryption and authorization processes of a first data packet have completed.

Abstract: Method and arrangement for dispersing fuel 62 within a fuel containment system 60 of an aircraft 30 including utilizing a fuel containment system on an aircraft that is located at least partially within a wing 34 of the aircraft and defines a reservoir portion 42 and a remote portion 44. Fuel is pumped during at least aircraft flight operation from the reservoir portion to the remote portion at a pumped rate 80, while simultaneously fuel that is contained in the remote portion of the fuel containment system is permitted to drain to the reservoir portion at a drainage rate 82. The drainage rate is less than the pumped rate. A fuel mass 64 is accumulated in the remote portion of the fuel containment system because of a difference between the pumped rate and the drainage rate and as a result, a counteractive moment 49 is induced in the aircraft that is opposingly directed to a lift moment 46 caused by wing-lift 45 during aircraft flight.

Abstract: The invention relates to 3,4-diaminopyridine salts, pharmaceutical compositions containing at least one of said salts and uses thereof for the treatment of botulism, myasthenia, myasthenic syndromes or fatigue.

Abstract: Peptides of the formulaR.sub.1 --HX.sub.1 DX.sub.2 IX.sub.3 Iwherein R.sub.1, X.sub.1, X.sub.2 and X.sub.3 are defined as in the specification having antihypertensive activity without vascoconstricting activity.